Will TrumpRx.gov list at least 25 discounted drugs by February 28, 2026?
236,906 Vol.5 months ago (Mar-01-2026 04:59:00 AM UTC)
DescriptionThis event tracks whether the official federal website TrumpRx.gov lists 25 or more unique prescription medications available for purchase or referral at discounted prices on or before February 28, 2026. For the purposes of this market, a drug is considered "listed" if it appears on the public-facing searchable database or official list on TrumpRx.gov as a medication that consumers can access at a negotiated, Most-Favored-Nation (MFN), or otherwise discounted rate.
-
- The count is based on unique drug names or active ingredients, regardless of different dosages or delivery methods (e.g., different strengths of the same medication count as one drug). Qualifying drugs must be part of the administration's direct-to-consumer initiative where prices are specifically reduced through federal agreements with pharmaceutical manufacturers. General information pages about drug categories that do not offer specific discounted pricing for a named medication do not count toward the total.
-
- The event resolves positively if at least 25 qualifying drugs are verifiable on the official TrumpRx.gov website by the close date. If the total number of unique drugs listed remains below 25 by February 28, 2026, the event resolves negatively. Verification will be based on live site audits, official White House fact sheets, or Department of Health and Human Services (HHS) announcements detailing the program's inventory.